Chicken β-defensin-1 peptide as a candidate anticoccidial agent in broiler chickens

Anim Biotechnol. 2023 Dec;34(7):3108-3125. doi: 10.1080/10495398.2022.2136677. Epub 2022 Oct 30.

Abstract

The current study aimed to investigate the potentiality of using avian β-defensin-1 peptide as a candidate agent against coccidiosis infection in broiler chicken.We employed an in-silico analysis to study the primary structure of β-defensin-1 peptide as well as its 3-D and molecular dynamic structures. This will also enable obtaining adequate information about the mode of action of these peptides and the intra-cellular transduction pathways. The results revealed no significant difference among groups of broiler chicken in terms of body weight before the Eimeria challenge.The results of our study indicated a significant reduction in oocyst count in birds administered β-defensin-1 peptide treatment, vis-a-vis healthy birds. The treated group showed a 2-3 times reduction in oocyst count, compared to the positive control group. The Eimeria oocysts count evaluated for birds administered with β-defensin-1 after the Eimeria challenge showed a significant difference. The study indicated significant reduction and down-regulation in the level of expression of β-defensin 1 and 4 in the control and treatment groups.This electrostatic profile and hydrophobicity regulate the functioning of this peptide. The results may help in the development of novel approaches that could be used as alternatives or adjunct to the existing means of coccidiosis control in broilers.

Keywords: 3D structure; Coccidiosis; Eimeria; broiler; β-defensin-1 peptide.

MeSH terms

  • Animals
  • Chickens
  • Coccidiosis* / drug therapy
  • Coccidiosis* / veterinary
  • Eimeria*
  • Oocysts
  • Poultry Diseases* / drug therapy
  • beta-Defensins* / pharmacology

Substances

  • beta-Defensins